WRITTEN BY THE LANCET ON 19 OCT 2020 THEY UNDERSTOOD THE "JAB" WAS NOT RIGHT AND IT HAS AN HIV RISK ATTATCHED We are writing to express concern about the use of a recombinant adenovirus type-5 (Ad5) vector for a COVID-19 phase 1 vaccine study,1 and subsequent advanced trials....See more